Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women
- Status
- UNKNOWN
- Phase
- PHASE2
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression
- Status
- COMPLETED
- Phase
- PHASE2